Cargando…

Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation

BACKGROUND: Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such margin...

Descripción completa

Detalles Bibliográficos
Autores principales: Uto, Keiichi, Sakamoto, Seisuke, Que, Weitao, Shimata, Keita, Hashimoto, Shintaro, Sakisaka, Masataka, Narita, Yasuko, Yoshii, Daiki, Zhong, Lin, Komohara, Yoshihiro, Li, Xiao-Kang, Inomata, Yukihiro, Hibi, Taizo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368804/
https://www.ncbi.nlm.nih.gov/pubmed/30736744
http://dx.doi.org/10.1186/s12876-019-0939-7
_version_ 1783394067922550784
author Uto, Keiichi
Sakamoto, Seisuke
Que, Weitao
Shimata, Keita
Hashimoto, Shintaro
Sakisaka, Masataka
Narita, Yasuko
Yoshii, Daiki
Zhong, Lin
Komohara, Yoshihiro
Li, Xiao-Kang
Inomata, Yukihiro
Hibi, Taizo
author_facet Uto, Keiichi
Sakamoto, Seisuke
Que, Weitao
Shimata, Keita
Hashimoto, Shintaro
Sakisaka, Masataka
Narita, Yasuko
Yoshii, Daiki
Zhong, Lin
Komohara, Yoshihiro
Li, Xiao-Kang
Inomata, Yukihiro
Hibi, Taizo
author_sort Uto, Keiichi
collection PubMed
description BACKGROUND: Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such marginal donors is therefore crucial for reducing the possibility of the primary non-function of grafts and graft loss. Some reports have found that molecular-hydrogen showed antioxidant and anti-inflammatory effects in preventing IRI in some non-hepatic transplant models. Therefore, we investigated whether or not molecular-hydrogen could attenuate IRI in LT model rats. METHODS: We used a hydrogen-rich water bath to dissolve hydrogen into solution and graft tissues and performed isogenic and orthotopic LT in Lewis rats with University of Wisconsin (UW) solution. Blood and tissue samples were collected 6 h after the reperfusion. Hepatic enzymes in serum were measured. Pathological findings including the expressions of cytokines and heme oxygenase (HO)-1 in liver tissues were evaluated. RESULTS: The concentration of hydrogen inside the graft tissues increased depending on the storage time, plateauing after 1 h. Serum liver enzyme levels were significantly lower and the histology score of liver damage markedly attenuated in the group given grafts preserved in hydrogen-rich UW solution than in the control group. The hydrogen-rich UW solution group also showed less oxidative damage and hepatocyte apoptosis than the control group, and the expression of proinflammatory cytokines tended to be lower while the protein levels of HO-1 were significantly increased (n = 3–12 per group, P < 0.05). CONCLUSIONS: Storage of liver grafts in hydrogen-rich UW solution resulted in superior functional and morphologic protection against IRI via the up-regulation of HO-1 expression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-019-0939-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6368804
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63688042019-02-15 Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation Uto, Keiichi Sakamoto, Seisuke Que, Weitao Shimata, Keita Hashimoto, Shintaro Sakisaka, Masataka Narita, Yasuko Yoshii, Daiki Zhong, Lin Komohara, Yoshihiro Li, Xiao-Kang Inomata, Yukihiro Hibi, Taizo BMC Gastroenterol Research Article BACKGROUND: Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such marginal donors is therefore crucial for reducing the possibility of the primary non-function of grafts and graft loss. Some reports have found that molecular-hydrogen showed antioxidant and anti-inflammatory effects in preventing IRI in some non-hepatic transplant models. Therefore, we investigated whether or not molecular-hydrogen could attenuate IRI in LT model rats. METHODS: We used a hydrogen-rich water bath to dissolve hydrogen into solution and graft tissues and performed isogenic and orthotopic LT in Lewis rats with University of Wisconsin (UW) solution. Blood and tissue samples were collected 6 h after the reperfusion. Hepatic enzymes in serum were measured. Pathological findings including the expressions of cytokines and heme oxygenase (HO)-1 in liver tissues were evaluated. RESULTS: The concentration of hydrogen inside the graft tissues increased depending on the storage time, plateauing after 1 h. Serum liver enzyme levels were significantly lower and the histology score of liver damage markedly attenuated in the group given grafts preserved in hydrogen-rich UW solution than in the control group. The hydrogen-rich UW solution group also showed less oxidative damage and hepatocyte apoptosis than the control group, and the expression of proinflammatory cytokines tended to be lower while the protein levels of HO-1 were significantly increased (n = 3–12 per group, P < 0.05). CONCLUSIONS: Storage of liver grafts in hydrogen-rich UW solution resulted in superior functional and morphologic protection against IRI via the up-regulation of HO-1 expression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-019-0939-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-08 /pmc/articles/PMC6368804/ /pubmed/30736744 http://dx.doi.org/10.1186/s12876-019-0939-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Uto, Keiichi
Sakamoto, Seisuke
Que, Weitao
Shimata, Keita
Hashimoto, Shintaro
Sakisaka, Masataka
Narita, Yasuko
Yoshii, Daiki
Zhong, Lin
Komohara, Yoshihiro
Li, Xiao-Kang
Inomata, Yukihiro
Hibi, Taizo
Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation
title Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation
title_full Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation
title_fullStr Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation
title_full_unstemmed Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation
title_short Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation
title_sort hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368804/
https://www.ncbi.nlm.nih.gov/pubmed/30736744
http://dx.doi.org/10.1186/s12876-019-0939-7
work_keys_str_mv AT utokeiichi hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT sakamotoseisuke hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT queweitao hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT shimatakeita hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT hashimotoshintaro hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT sakisakamasataka hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT naritayasuko hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT yoshiidaiki hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT zhonglin hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT komoharayoshihiro hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT lixiaokang hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT inomatayukihiro hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation
AT hibitaizo hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation